Jeffrey A. Winkles
Affiliations: | The George Washington University, Washington, DC, United States |
Area:
Genetics, Molecular Biology, Cell BiologyGoogle:
"Jeffrey Winkles"Children
Sign in to add trainee| Gregory F. Alberts | grad student | 2003 | The George Washington University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Connolly NP, Galisteo R, Xu S, et al. (2021) Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer. Glia |
| Alvarez de Cienfuegos A, Cheung LH, Mohamedali KA, et al. (2020) Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B. Journal For Immunotherapy of Cancer. 8 |
| Dancy JG, Wadajkar AS, Connolly NP, et al. (2020) Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer. Science Advances. 6: eaax3931 |
| Roberts NB, Alqazzaz A, Hwang JR, et al. (2018) Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction. Journal of Neuro-Oncology |
| Hersh DS, Harder BG, Roos A, et al. (2018) The TNF Receptor Family Member Fn14 is Highly Expressed in Recurrent Glioblastoma (GBM) and in GBM Patient-Derived Xenografts With Acquired Temozolomide Resistance. Neuro-Oncology |
| Roos A, Dhruv HD, Peng S, et al. (2018) EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival. Molecular Cancer Research : McR |
| Hersh DS, Peng S, Dancy JG, et al. (2018) Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas. Journal of Neuro-Oncology |
| Connolly NP, Shetty AC, Stokum JA, et al. (2018) Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma. Scientific Reports. 8: 1180 |
| Harder B, Sereduk C, Dhruv H, et al. (2018) Abstract 4910: Development of an antagonist to the TWEAK-Fn14 ligand-receptor interaction with enhanced efficacy/potency in glioblastoma cells Cancer Research. 78: 4910-4910 |
| Wadajkar AS, Dancy JG, Roberts NB, et al. (2017) Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas. Journal of Controlled Release : Official Journal of the Controlled Release Society |